Evidence map›Paper›PMID 38731071›Full record

ArticleJournal of clinical medicine2024

The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Glomerular Activity in COVID-19 and Diabetes Mellitus.

Shengyuan Xu, Michael Hultström, Anders Larsson, Miklos Lipcsey, Cecilia Lindskog, Sara Bülow, Robert Frithiof, Per Venge

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shengyuan XuDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, SE-751 85 Uppsala, Sweden.
Michael HultströmDepartment of Medical Cell Biology, Integrative Physiology, Uppsala University, SE-751 23 Uppsala, Sweden.ORCID 0000-0003-4675-1099
Anders LarssonDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, SE-751 85 Uppsala, Sweden.ORCID 0000-0003-3161-0402
Miklos LipcseyDepartment of Surgical Sciences, Anaesthesiology and Intensive Care, Uppsala University, SE-751 85 Uppsala, Sweden.ORCID 0000-0002-1976-4129
Cecilia LindskogDepartment of Immunology, Genetics and Pathology, Uppsala University; SE-751 23 Uppsala, Sweden.
Sara BülowDepartment of Surgical Sciences, Anaesthesiology and Intensive Care, Uppsala University, SE-751 85 Uppsala, Sweden.
Robert FrithiofDepartment of Surgical Sciences, Anaesthesiology and Intensive Care, Uppsala University, SE-751 85 Uppsala, Sweden.ORCID 0000-0003-2278-7951
Per VengeDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, SE-751 85 Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute kidney injury (AKI)cystatin CKIM-1lipocalinNGAL

Identifiers

PMID38731071
PMCPMC11084804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.